Inventor

ZHENG XIAOZHANG

US110 patents

⚠️ This page may combine multiple inventors who share the name “ZHENG XIAOZHANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZHENG XIAOZHANG

FORMA THERAPEUTICS INC

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors

3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors

Compositions for activating pyruvate kinase

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Compositions for activating pyruvate kinase

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Compositions for activating pyruvate kinase

KYMERA THERAPEUTICS INC

IRAK degraders and uses thereof

IRAK degraders and uses thereof

IRAK degraders and uses thereof

IRAK degraders and uses thereof

IRAK degraders and uses thereof

VALO EARLY DISCOVERY INC

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

BAIR KENNETH W

Compounds and compositions for the inhibition of NAMPT

Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives

Compounds and compositions for the inhibition of NAMPT

NEUROGEN CORP

Substituted quinazolin-4-ylamine analogues

Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines

VALO HEALTH INC

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

PFIZER

Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines

GENENTECH INC

Amido spirocyclic amide and sulfonamide derivatives

NOVO NORDISK HEALTHCARE AG

Treating sickle cell disease with a pyruvate kinase R activating compound